Type VI collagen in the cardiac valves and connective tissue septa during heart development

G. T. Kitten, S. J. Kolker, S. L. Krob, Scott E Klewer

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A variety of extracellular matrix (ECM) proteins have been shown to be present in the embryonic heart during the morphogenesis of the valves and membranous septa. It is not known if any specific ECM protein is required for the normal morphogenesis of these tissues, but this is of great interest since there is a high incidence of congenital malformations which affect valvular and septal tissues. Interestingly, the α1 and α2 genes of type VI collagen are located within the region of human chromosome 21 thought to be involved in the congenital heart defect phenotype associated with trisomy 21 (Down's syndrome). In this study we examined the distribution and investigated the function of type VI collagen in the cardiac valves and septa of chicken and mouse embryos during various stages of development. Immunohistochemical and in situ hybridization studies revealed a pattern of cardiac expression of type VI collagen which is present from the earliest stages of valve and septum development through the neonatal period. Results from an in vitro bioassay suggest that type VI collagen may play a role in the formation and migration of specific cells in the forming valves and septa. These data support molecular genetic studies which have indicated that type VI collagen is involved in the heart defect phenotype seen in trisomy 21.

Original languageEnglish (US)
Pages (from-to)1189-1193
Number of pages5
JournalBrazilian Journal of Medical and Biological Research
Volume29
Issue number9
StatePublished - Sep 1996
Externally publishedYes

Fingerprint

Heart Septum
Collagen Type VI
Heart Valves
connective tissues
Connective Tissue
collagen
heart
Tissue
Down Syndrome
trisomics
Extracellular Matrix Proteins
Morphogenesis
extracellular matrix
morphogenesis
neonatal development
congenital abnormalities
Down syndrome
Phenotype
phenotype
Chromosomes, Human, Pair 21

Keywords

  • Development
  • Extracellular matrix
  • Heart
  • Type VI collagen
  • Valves

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Medicine (miscellaneous)

Cite this

Type VI collagen in the cardiac valves and connective tissue septa during heart development. / Kitten, G. T.; Kolker, S. J.; Krob, S. L.; Klewer, Scott E.

In: Brazilian Journal of Medical and Biological Research, Vol. 29, No. 9, 09.1996, p. 1189-1193.

Research output: Contribution to journalArticle

@article{fc4619d936874132a01854bf4d0aac82,
title = "Type VI collagen in the cardiac valves and connective tissue septa during heart development",
abstract = "A variety of extracellular matrix (ECM) proteins have been shown to be present in the embryonic heart during the morphogenesis of the valves and membranous septa. It is not known if any specific ECM protein is required for the normal morphogenesis of these tissues, but this is of great interest since there is a high incidence of congenital malformations which affect valvular and septal tissues. Interestingly, the α1 and α2 genes of type VI collagen are located within the region of human chromosome 21 thought to be involved in the congenital heart defect phenotype associated with trisomy 21 (Down's syndrome). In this study we examined the distribution and investigated the function of type VI collagen in the cardiac valves and septa of chicken and mouse embryos during various stages of development. Immunohistochemical and in situ hybridization studies revealed a pattern of cardiac expression of type VI collagen which is present from the earliest stages of valve and septum development through the neonatal period. Results from an in vitro bioassay suggest that type VI collagen may play a role in the formation and migration of specific cells in the forming valves and septa. These data support molecular genetic studies which have indicated that type VI collagen is involved in the heart defect phenotype seen in trisomy 21.",
keywords = "Development, Extracellular matrix, Heart, Type VI collagen, Valves",
author = "Kitten, {G. T.} and Kolker, {S. J.} and Krob, {S. L.} and Klewer, {Scott E}",
year = "1996",
month = "9",
language = "English (US)",
volume = "29",
pages = "1189--1193",
journal = "Brazilian Journal of Medical and Biological Research",
issn = "0100-879X",
publisher = "Associacao Brasileira de Divulgacao Cientifica",
number = "9",

}

TY - JOUR

T1 - Type VI collagen in the cardiac valves and connective tissue septa during heart development

AU - Kitten, G. T.

AU - Kolker, S. J.

AU - Krob, S. L.

AU - Klewer, Scott E

PY - 1996/9

Y1 - 1996/9

N2 - A variety of extracellular matrix (ECM) proteins have been shown to be present in the embryonic heart during the morphogenesis of the valves and membranous septa. It is not known if any specific ECM protein is required for the normal morphogenesis of these tissues, but this is of great interest since there is a high incidence of congenital malformations which affect valvular and septal tissues. Interestingly, the α1 and α2 genes of type VI collagen are located within the region of human chromosome 21 thought to be involved in the congenital heart defect phenotype associated with trisomy 21 (Down's syndrome). In this study we examined the distribution and investigated the function of type VI collagen in the cardiac valves and septa of chicken and mouse embryos during various stages of development. Immunohistochemical and in situ hybridization studies revealed a pattern of cardiac expression of type VI collagen which is present from the earliest stages of valve and septum development through the neonatal period. Results from an in vitro bioassay suggest that type VI collagen may play a role in the formation and migration of specific cells in the forming valves and septa. These data support molecular genetic studies which have indicated that type VI collagen is involved in the heart defect phenotype seen in trisomy 21.

AB - A variety of extracellular matrix (ECM) proteins have been shown to be present in the embryonic heart during the morphogenesis of the valves and membranous septa. It is not known if any specific ECM protein is required for the normal morphogenesis of these tissues, but this is of great interest since there is a high incidence of congenital malformations which affect valvular and septal tissues. Interestingly, the α1 and α2 genes of type VI collagen are located within the region of human chromosome 21 thought to be involved in the congenital heart defect phenotype associated with trisomy 21 (Down's syndrome). In this study we examined the distribution and investigated the function of type VI collagen in the cardiac valves and septa of chicken and mouse embryos during various stages of development. Immunohistochemical and in situ hybridization studies revealed a pattern of cardiac expression of type VI collagen which is present from the earliest stages of valve and septum development through the neonatal period. Results from an in vitro bioassay suggest that type VI collagen may play a role in the formation and migration of specific cells in the forming valves and septa. These data support molecular genetic studies which have indicated that type VI collagen is involved in the heart defect phenotype seen in trisomy 21.

KW - Development

KW - Extracellular matrix

KW - Heart

KW - Type VI collagen

KW - Valves

UR - http://www.scopus.com/inward/record.url?scp=0030224343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030224343&partnerID=8YFLogxK

M3 - Article

C2 - 9181062

AN - SCOPUS:0030224343

VL - 29

SP - 1189

EP - 1193

JO - Brazilian Journal of Medical and Biological Research

JF - Brazilian Journal of Medical and Biological Research

SN - 0100-879X

IS - 9

ER -